United Orthopedic (4129) - Total Liabilities

Latest as of September 2025: NT$3.44 Billion TWD ≈ $108.23 Million USD

Based on the latest financial reports, United Orthopedic (4129) has total liabilities worth NT$3.44 Billion TWD (≈ $108.23 Million USD) as of September 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Explore United Orthopedic (4129) cash flow conversion to assess how effectively this company generates cash.

United Orthopedic - Total Liabilities Trend (2015–2024)

This chart illustrates how United Orthopedic's total liabilities have evolved over time, based on quarterly financial data. Check asset resilience ratio of United Orthopedic to evaluate the company's liquid asset resilience ratio.

United Orthopedic Competitors by Total Liabilities

The table below lists competitors of United Orthopedic ranked by their total liabilities.

Company Country Total Liabilities
Envipco Holding N.V.
AS:ENVI
Netherlands €55.32 Million
Fabryka Farb i Lakierów ŚNIEŻKA SA
WAR:SKA
Poland zł364.14 Million
Fluxys Belgium
BR:FLUX
Belgium €2.73 Billion
Hyliion Holdings Corp.
NYSE:HYLN
USA $12.38 Million
Petron Malaysia Refining Marketing
KLSE:3042
Malaysia RM1.52 Billion
BTS Group AB (publ)
ST:BTS-B
Sweden Skr1.73 Billion
PRUKSA HOLDING
BK:PSH-R
Thailand ฿24.59 Billion
Dasheng Times Cultural Investment Co Ltd
SHG:600892
China CN¥477.97 Million

Liability Composition Analysis (2015–2024)

This chart breaks down United Orthopedic's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see 4129 market cap.

Liquidity & Leverage Metrics

Key Metrics Explained

Metric Value Description
Current Ratio 1.79 Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio N/A More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio N/A Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity 0.88 Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets 0.46 Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how United Orthopedic's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for United Orthopedic (2015–2024)

The table below shows the annual total liabilities of United Orthopedic from 2015 to 2024.

Year Total Liabilities Change
2024-12-31 NT$3.09 Billion
≈ $97.34 Million
+9.45%
2023-12-31 NT$2.82 Billion
≈ $88.93 Million
+11.77%
2022-12-31 NT$2.53 Billion
≈ $79.57 Million
+4.19%
2021-12-31 NT$2.42 Billion
≈ $76.38 Million
-8.94%
2020-12-31 NT$2.66 Billion
≈ $83.87 Million
+15.21%
2019-12-31 NT$2.31 Billion
≈ $72.80 Million
-11.11%
2018-12-31 NT$2.60 Billion
≈ $81.90 Million
+25.14%
2017-12-31 NT$2.08 Billion
≈ $65.45 Million
+79.97%
2016-12-31 NT$1.15 Billion
≈ $36.36 Million
+40.73%
2015-12-31 NT$820.18 Million
≈ $25.84 Million
--

About United Orthopedic

TWO:4129 Taiwan Medical Devices
Market Cap
$298.97 Million
NT$9.49 Billion TWD
Market Cap Rank
#14978 Global
#626 in Taiwan
Share Price
NT$98.40
Change (1 day)
-0.61%
52-Week Range
NT$85.50 - NT$131.00
All Time High
NT$131.00
About

United Orthopedic Corporation engages in the research, development, manufacture, and sale of orthopedic implants and surgical instruments in Taiwan, Asia, America, Europe, Africa, and Oceania. The company offers artificial hip joints, partial hip joints, joints for large trochanteric fractures, Moore hip prostheses, and customized artificial hip joints for individual tumor patients; artificial kn… Read more